Mutations in the gene encoding epithelial growth factor receptor (EGFR), rearrangements of the gene encoding anaplastic lymphoma kinase (ALK), and other oncogenic drivers, such as BRAF, are the most common genomic changes in lung cancer. The gene discussed is ALK; the disease is lung carcinoma.